Evidence map›Paper›PMID 30791593›Full record

ArticleMolecules (Basel, Switzerland)2019

Synthesis and Antiproliferative Activity of Novel Heterocyclic Glycyrrhetinic Acid Derivatives.

Daniela P S Alho, Jorge A R Salvador, Marta Cascante, Silvia Marin

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Microbiology · 2023
    Article
  9. Article
  10. Article
  11. Novel SynthesizedInternational journal of molecular sciences · 2021
    Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Daniela P S AlhoLaboratory of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal. dani.alho23@gmail.com.ORCID 0000-0003-1564-6528
Jorge A R SalvadorLaboratory of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal. salvador@ci.uc.pt.
Marta CascanteDepartment of Biochemistry and Molecular Biomedicine, Faculty of Biology, University of Barcelona, Diagonal 643, 08028 Barcelona, Spain. martacascante@ub.edu.
Silvia MarinDepartment of Biochemistry and Molecular Biomedicine, Faculty of Biology, University of Barcelona, Diagonal 643, 08028 Barcelona, Spain. silviamarin@ub.edu.ORCID 0000-0003-0693-2207
Centro de Neurociências e Biologia Celular · PTInstituto de Salud Carlos III · ES

Funding

NCI CLINICAL INVESTIGATOR AWARD PROGRAMK08CA001017 · NCI · UNIVERSITY OF COLORADO DENVER · PI DRABKIN, HARRY ADOLPH · 1985 to 1987
–
Agència de Gestió d'Ajuts Universitaris i de Recerca (AGAUR) - Generalitat de Catalunya 2014SGR1017FEDER and FCT REEQ/481/QUI/2006, RECI/QEQ-FI/0168/2012 and CENTRO-07-CT62-FEDER-002012Fundação para a Ciência e Tecnologia (FCT) SFRH/BD/66020/2009MINECO-European Commission FEDER SAF2014-56059-RPT2020 (Programa Operacional do Centro 2020), and the financial support by FEDER (European Regional Development Fund) through the COMPETE 2020 Programme (Operational Programme for Competitiveness and Internationalisation) Grant nº 3269, drugs2CAD
6 · The paper itself

Abstract

A new series of glycyrrhetinic acid derivatives has been synthesized via the introduction of different heterocyclic rings conjugated with an α,β-unsaturated ketone in its ring A. These new compounds were screened for their antiproliferative activity in a panel of nine human cancer cell lines. Compound

Indexed as

Antineoplastic AgentsApoptosisCell CycleCell Line, TumorCell SurvivalChemistry Techniques, SyntheticGlycyrrhetinic AcidHumansMolecular StructureAntineoplastic AgentsGlycyrrhetinic Acidantiproliferative activityapoptosisglycyrrhetinic acidheterocyclic derivativespentacyclic triterpenoids

Identifiers

PMID30791593
PMCPMC6412232
OpenAlexW2917160502

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.